Floatz logo

Mpd-1

Biomarkers

Pharosgen Co.,LtdPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Biomarkers cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Oncology Center of Biochemical Education And Research
D
ETOPOSIDE
Oncology Center of Biochemical Education And Research
D
Atezolizumab
Oncology Center of Biochemical Education And Research
D
Carboplatin
Oncology Center of Biochemical Education And Research
D

Same molecule, other indications

Mpd-1 is also rated in:

Solid Tumor CancerDormant
C
Indicative ·
39 / 100
View asset →
cancerDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →